TipRanks
Spero Therapeutics Inc (DE:2HA)
FRANKFURT:2HA
Germany Market
2HA
Spero Therapeutics
RESEARCH TOOLSreports

Spero Therapeutics (2HA) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

2HA Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Spero
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2HA Stock 12 Month Forecast

There Are No Analyst Ratings for DE:2HA In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

2HA Financial Forecast

2HA Earnings Forecast

Next quarter’s earnings estimate for 2HA is -€0.12 with a range of -€0.12 to -€0.12. The previous quarter’s EPS was -€0.14. 2HA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2HA has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2HA is -€0.12 with a range of -€0.12 to -€0.12. The previous quarter’s EPS was -€0.14. 2HA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2HA has Performed in-line its overall industry.

2HA Sales Forecast

Next quarter’s sales forecast for 2HA is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 2HA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2HA has Performed in-line its overall industry.
Next quarter’s sales forecast for 2HA is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 2HA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2HA has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on DE:2HA
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
€3.5
Hold
239.50%
Upside
Reiterated
12/17/25
Evercore ISI Keeps Their Hold Rating on Spero Therapeutics (SPRO)
TD Cowen Analyst forecast on DE:2HA
Ritu Baral
TD Cowen
TD Cowen
―
Hold
―
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Spero Therapeutics (NASDAQ: SPRO), Kodiak Sciences (NASDAQ: KOD) and VolitionRX (NYSE MKT: VNRX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on DE:2HA
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
€3.5
Hold
239.50%
Upside
Reiterated
12/17/25
Evercore ISI Keeps Their Hold Rating on Spero Therapeutics (SPRO)
TD Cowen Analyst forecast on DE:2HA
Ritu Baral
TD Cowen
TD Cowen
―
Hold
―
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Spero Therapeutics (NASDAQ: SPRO), Kodiak Sciences (NASDAQ: KOD) and VolitionRX (NYSE MKT: VNRX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
ESTAEstablishment Labs Holdings
LGNDLigand Pharma
KURAKura Oncology
ZYMEZymeworks
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2HA Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 2HA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2HA average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

2HA Stock Forecast FAQ

What is DE:2HA’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:2HA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:2HA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Spero Therapeutics Inc a Buy, Sell or Hold?
      Currently, no data Available
      What is Spero Therapeutics Inc’s share price target?
      Currently, no data Available
      What do analysts say about Spero Therapeutics Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Spero Therapeutics Inc?
      To buy shares of DE:2HA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.